FDA Approves Biosimilar to Humira – IBD in the News

The FDA recently approved a biosimilar (Amjevita) to Humira, which is indicated for multiple inflammatory diseases, including Crohn’s disease and ulcerative colitis. Dr. Edward Loftus discusses some of the issues surrounding this drug.


Leave a Reply

Your email address will not be published. Required fields are marked *